---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-104368"
form_type: "8-K"
ticker: "BRNS"
cik: "0001828185"
company_name: "Barinthus Biotherapeutics plc."
filed_at: "2026-09-01T21:13:23+00:00"
generated_at: "2026-09-01T21:14:19.919801+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Barinthus Biotherapeutics: Court sanctions scheme; merger effective Sept 9, trading halt ahead

## Summary
- Court sanctioned Scheme of Arrangement and share premium capital reduction on Sept 1, 2026.
- Scheme expected to become effective Sept 9, 2026; ADS trading halt expected before open that day.
- Merger with Clywedog Therapeutics (per Sept 29, 2025 agreement) on track; delisting/deregistration plans unchanged.

## SEC filing metadata
- accession: 0001104659-26-104368
- form_type: 8-K
- ticker: BRNS
- cik: 0001828185
- company_name: Barinthus Biotherapeutics plc.
- filed_at: 2026-09-01T21:13:23+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1828185/000110465926104368/0001104659-26-104368-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1828185/000110465926104368/tm2624619d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-104368
- JSON: https://secwatch.observer/filing/0001104659-26-104368.json
- Plain text: https://secwatch.observer/filing/0001104659-26-104368.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.